These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3522442

  • 21. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ.
    Am J Med; 1987 Apr 27; 82(4A):202-7. PubMed ID: 3555037
    [Abstract] [Full Text] [Related]

  • 22. [Clinical observations on a new synthetic mucolytic].
    Zacco R, Fornaroli E.
    Clin Ter; 1968 Nov 15; 47(3):247-57. PubMed ID: 4911792
    [No Abstract] [Full Text] [Related]

  • 23. [Fenspiride in patients with acute bronchitis].
    Płusa T, Ochwat A.
    Pol Merkur Lekarski; 2005 Jul 15; 19(109):32-6. PubMed ID: 16194023
    [Abstract] [Full Text] [Related]

  • 24. [N-acetylcystein in the therapy of chronic bronchitis].
    Reichenberger F, Tamm M.
    Pneumologie; 2002 Dec 15; 56(12):793-7. PubMed ID: 12486618
    [Abstract] [Full Text] [Related]

  • 25. Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
    Pozzi E, Dolcetti A, Orlandi O, Cirianni C, Moreo G, Piacenza G, Rampulla C, Fugazza L, Scarpazza G.
    Arzneimittelforschung; 1994 Dec 15; 44(12A):1495-8. PubMed ID: 7857350
    [Abstract] [Full Text] [Related]

  • 26. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E, Bonizzoni D, Cattaneo E, Scevola D, Concia E.
    Minerva Med; 1975 Apr 04; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract] [Full Text] [Related]

  • 27. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
    Aleksa VI, Prozorova VK, Mal'tseva NA, Shatikhina LN.
    Ter Arkh; 2001 Apr 04; 73(3):48-51. PubMed ID: 11417181
    [Abstract] [Full Text] [Related]

  • 28. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H, Charpin J, Germouty J.
    Eur J Respir Dis Suppl; 1980 Apr 04; 111():65-9. PubMed ID: 7011834
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in combination with antibiotic and bronchoactive therapy in adult patients with acute and chronic bronchopneumopathy with prevalent exudative component].
    Casali L.
    Boll Chim Farm; 1990 Apr 04; 129(10-11):49S-52S. PubMed ID: 2102701
    [Abstract] [Full Text] [Related]

  • 30. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
    Fadda G.
    Minerva Med; 2001 Aug 04; 92(4):269-75. PubMed ID: 11535970
    [Abstract] [Full Text] [Related]

  • 31. [Experiences with the mucolytic agent Bisolvon: its effect on sputum production].
    Gürtler J.
    Praxis; 1965 Aug 12; 54(32):948-53. PubMed ID: 5320017
    [No Abstract] [Full Text] [Related]

  • 32. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M, Szwed H, Kowalik I, Sadowski Z.
    Pol Merkur Lekarski; 2002 Jul 12; 13(73):52-5. PubMed ID: 12362508
    [Abstract] [Full Text] [Related]

  • 33. [Secretolytic bisolvon in the treatment of chronic bronchitis and bronchial asthma].
    Beritić T.
    Lijec Vjesn; 1968 Jul 12; 90(8):775-9. PubMed ID: 4888799
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies].
    Bandera M, Fioretti M.
    Clin Ter; 1984 Sep 15; 110(5):455-61. PubMed ID: 6238760
    [No Abstract] [Full Text] [Related]

  • 35. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
    Primer G.
    Ther Ggw; 1975 Aug 15; 114(8):1251-66. PubMed ID: 1108276
    [No Abstract] [Full Text] [Related]

  • 36. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG.
    Scand J Respir Dis Suppl; 1974 Aug 15; 90():1-89. PubMed ID: 4618374
    [No Abstract] [Full Text] [Related]

  • 37. [Trial of a new synthetic fluidifying and analeptic agent: sobrerol. Its use in inflammatory bronchopneumopathies].
    Marchioni CF, Monzali G.
    Clin Ter; 1972 Jan 31; 60(2):135-42. PubMed ID: 4401338
    [No Abstract] [Full Text] [Related]

  • 38. [The treatment of bronchial inflammatory diseases with a new drug association with mucolytic and expectorant activity].
    Moncalvo F, Rossi A.
    Clin Ter; 1971 Jul 31; 57(6):505-26. PubMed ID: 5136487
    [No Abstract] [Full Text] [Related]

  • 39. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J, Poderoso JJ, Corazza C, Fernández M, Guerreiro RB, Wiemeyer JC.
    Arzneimittelforschung; 1987 Aug 31; 37(8):969-71. PubMed ID: 3675696
    [Abstract] [Full Text] [Related]

  • 40. A clinical trial of bromhexine.
    Thompson KJ, Reeve J.
    N Z Med J; 1972 Aug 31; 76(483):73-6. PubMed ID: 4264310
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.